Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent
Journal article
Adekola, Tolulope Anthony. (2020). Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent. European Intellectual Property Review. 42(11), pp. 695-697.
Authors | Adekola, Tolulope Anthony |
---|---|
Abstract | As the world continues to battle the Covid-19 pandemic, innovation and technology have found a new battleground. Against the backdrop of the emerging patent controversies surrounding Covid-19 vaccines and therapeutics, this opinion reconsiders the theoretical justification for the grant of pharmaceutical patents. |
Keywords | coronavirus; morals and law; patentable inventions; patents; pharmaceuticals |
Year | 2020 |
Journal | European Intellectual Property Review |
Journal citation | 42 (11), pp. 695-697 |
Publisher | Sweet & Maxwell |
ISSN | 0142-0461 |
Page range | 695-697 |
Publisher's version | License All rights reserved File Access Level Controlled |
Output status | Published |
Publication dates | |
Online | 2021 |
Publication process dates | |
Deposited | 02 Jun 2025 |
Additional information | © 2021 Sweet & Maxwell and its Contributors |
Permalink -
https://acuresearchbank.acu.edu.au/item/91y22/should-covid-19-treatment-be-patented-rethinking-the-theoretical-justification-for-the-grant-of-pharmaceutical-patent
Restricted files
Publisher's version
(1 files)
9
total views0
total downloads9
views this month0
downloads this month